Researchers focus on its involvement in circadian rhythm modulation, central nervous system signaling, and peptide-based communication within the body
Some practitioners do combine Dihexa and Cerebrolysin, as their mechanisms are complementary Cerebrolysin offers broad multi-target neurotrophic support while Dihexa targets specific synaptogenesis
For example, physical hindrances can include fatigue, discomfort, and underlying medical conditions
GHK-Cus clinical evidence covers a broader range of endpoints
However, these reports often lack detailed methodologies, making it difficult to assess the true impact of the peptide
We treat bioavailability as a non-negotiable standard